Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFN α-2b, and retinoic acid treatment over 2 years of follow-up

Can J Ophthalmol. 2024 Apr 6:S0008-4182(24)00070-X. doi: 10.1016/j.jcjo.2024.03.011. Online ahead of print.NO ABSTRACTPMID:38593982 | DOI:10.1016/j.jcjo.2024.03.011

Source: Canadian Journal of Ophthalmology - April 9, 2024 Category: Opthalmology Authors: Brooklyn Rawlyk Malshi Karunatilake Mussawar Iqbal Ryan Eidsness Source Type: research